为您找到相关结果约30个

你是不是要搜索 期刊Incyte 点击跳转

Incyte, MacroGenics pen cancer deal

Lilly, Incyte reel from FDA rejection

DRUG DEVELOPMENT Incyte, Calithera join for arginase inhibitor

CANCER Incyte drug failure casts shadow on IDO class

Incyte announces European Commission Approval of Pemazyre (R) (Pemigatinib) for the Treatment of Adults

A comparative study of the recent most potent small-molecule PD-L1 inhibitors: what can we learn?

Retifanlimab: First Approval

Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion

A patent review of anticancer CDK2 inhibitors (2017-present)

Capmatinib: First Approval

Baricitinib: First Global Approval

Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3-Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors

Managing side effects of JAK inhibitors for myelofibrosis in clinical practice

Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: A 52-week, randomized, single-blind, extension study

Pemigatinib Fibroblast growth factor receptor inhibitor Treatment of cholangiocarcinoma

为您找到相关结果约30个

共30条页码: 1/2页15条/页